Dare Bioscience Inc (DARE.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|63||2017||Independent Chairman of the Board|
|2017||President, Chief Executive Officer, Secretary, Director|
|48||2017||Principal Financial Officer|
|2017||Chief Financial Officer|
|52||2015||Principal Accounting Officer, Controller, Assistant Treasurer|
- BRIEF-Daré Bioscience Begins Trial For Contraceptive Candidate Ovaprene
- BRIEF-Daré Bioscience Appoints John Fair To Chief Business Officer
- BRIEF-Daré Bioscience Enters Into Agreement To Acquire Product To Address Vulvar And Vaginal Atrophy In Hormone Receptor-Positive Breast Cancer Patients
- BRIEF-Daré Bioscience Enters Into Exclusive Worldwide License Agreement For Juniper Pharmaceuticals’ Intravaginal Ring (IVR) Technology Platform
- BRIEF-Dare Bioscience Says Board Increased Size To 6 Directors